Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative Analysis
Open Access
- 8 May 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 6 (7), 1586-1599
- https://doi.org/10.1111/j.1600-6143.2006.01362.x
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Comparison of Two Methods to Detect Publication Bias in Meta-analysisJAMA, 2006
- Management of hepatitis C virus infection in the setting of liver transplantationLiver Transplantation, 2005
- 104 IFN/Riba treatment for recurrent hepatitis C after liver transplantation: Progression of hepatic fibrosis is favourably affected in both virological and biochemical sustained respondersJournal of Hepatology, 2004
- 489 Pegylated interferon plus ribavirin for the treatment of recurrent HCV infection after liver transplantationJournal of Hepatology, 2004
- Changing faces—natural course and treatment of hepatitis C after liver transplantationJournal of Hepatology, 2004
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Preliminary results of naive combination therapy with 12KDA peg-IFN α-2B and ribavirin in recurrent hepatitis C after liver transplantation (LT)Journal of Hepatology, 2003
- Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinomaJournal of Hepatology, 1996
- Inborn/outborn status and neonatal survival: A meta‐analysis of non‐randomized studiesStatistics in Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986